(2023)
PINK1 and Parkin rescue motor defects and mitochondria dysfunction induced by a patient-derived HSPB3 mutant in Drosophila models.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS.
682,
(2023)
An on-demand bioresorbable neurostimulator.
NATURE COMMUNICATIONS.
14,
1
(2023)
Whole-genome sequencing in clinically diagnosed Charcot-Marie-Tooth disease undiagnosed by whole-exome sequencing.
BRAIN COMMUNICATIONS.
5,
3
(2023)
PINK1 and Parkin Ameliorate the Loss of Motor Activity and Mitochondrial Dysfunction Induced by Peripheral Neuropathy-Associated HSPB8 Mutants in Drosophila Models.
BIOMEDICINES.
11,
3
(2022)
Peripheral Myelin Protein 22 Gene Mutations in Charcot-Marie-Tooth Disease Type 1E Patients.
GENES.
13,
7
(2022)
Cytokines secreted by mesenchymal stem cells reduce demyelination in an animal model of Charcot-Marie-Tooth disease.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS.
597,
(2022)
Virus blocking textile for SARS-CoV-2 using human body triboelectric energy harvesting.
CELL REPORTS PHYSICAL SCIENCE.
3,
4
(2022)
Genetic and Clinical Studies of Peripheral Neuropathies with Three Small Heat Shock Protein Gene Variants in Korea.
GENES.
13,
3
(2022)
HDAC6 Inhibition Corrects Electrophysiological and Axonal Transport Deficits in a Human Stem Cell-Based Model of Charcot-Marie-Tooth Disease (Type 2D).
ADVANCED BIOLOGY.
6,
2
(2021)
Farnesol ameliorates demyelinating phenotype in a cellular and animal model of charcot-marie-tooth disease type 1a.
CURRENT ISSUES IN MOLECULAR BIOLOGY.
43,
3
(2021)
Intraepineurial fat quantification and cross-sectional area analysis of the sciatic nerve using MRI in Charcot-Marie-Tooth disease type 1A patients.
SCIENTIFIC REPORTS.
11,
1
(2021)
Cerebellar white matter abnormalities in charcot–marie–tooth disease: A combined volumetry and diffusion tensor imaging analysis.
JOURNAL OF CLINICAL MEDICINE.
10,
21
(2021)
Human Induced Pluripotent Stem Cell-Derived TDP-43 Mutant Neurons Exhibit Consistent Functional Phenotypes Across Multiple Gene Edited Lines Despite Transcriptomic and Splicing Discrepancies.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY.
9,
(2021)
Novel homozygous mutations in Pakistani families with Charcot-Marie-Tooth disease.
BMC MEDICAL GENOMICS.
14,
1
(2021)
Clinical and Neuroimaging Features in Charcot-Marie-Tooth Patients with GNB4 Mutations.
LIFE-BASEL.
11,
6
(2021)
Texture analysis using T1-weighted images for muscles in Charcot-Marie-Tooth disease patients and volunteers.
EUROPEAN RADIOLOGY.
1,
1
(2020)
Short hairpin RNA treatment improves gait in a mouse model of Charcot-Marie-Tooth disease type 1A.
MOLECULAR MEDICINE REPORTS.
22,
6
(2020)
Wearable hip-assist robot modulates cortical activation during gait in stroke patients: a functional near-infrared spectroscopy study.
JOURNAL OF NEUROENGINEERING AND REHABILITATION.
17,
1
(2020)
Fibulin 5, a human Wharton's jelly-derived mesenchymal stem cells-secreted paracrine factor, attenuates peripheral nervous system myelination defects through the Integrin-RAC1 signaling axis.
STEM CELLS.
38,
12
(2020)
Psychoacoustics and neurophysiological auditory processing in patients with Charcot-Marie-Tooth disease types 1A and 2A.
EUROPEAN JOURNAL OF NEUROLOGY.
27,
10
Patent/Intellectual Property
샤르코-마리-투스병 진단용 마커 및 그의 용도(Marker for diagnosing Charcot-Marie-Tooth disease and use thereof).
10-1967-8800000.
20190404.
KOREA, REPUBLIC OF
샤르코-마리-투스병 진단용 마커 및 그의 용도(Marker for diagnosing Charcot-Marie-Tooth disease and use thereof).
10-1967-8810000.
20190404.
KOREA, REPUBLIC OF
샤르코-마리-투스 질환 진단용 키트(Kit for Diagnosing Charcot-Marie-Tooth).
10-1929-1640000.
20181207.
KOREA, REPUBLIC OF
샤르코-마리-투스 질환 진단용 키트(Kit for Diagnosing Charcot-Marie-Tooth).
10-1929-1650000.
20181207.
KOREA, REPUBLIC OF
샤르코-마리-투스 질환 진단용 키트(Kit for Diagnosing Charcot-Marie-Tooth).
10-1896-1470000.
20181207.
KOREA, REPUBLIC OF
샤르코-마리-투스 질환 진단용 키트(Kit for Diagnosing Charcot-Marie-Tooth).
10-1929-1650000.
20181207.
KOREA, REPUBLIC OF
샤르코-마리-투스 질환 진단용 키트(Kit for Diagnosing Charcot-Marie-Tooth).
10-1929-1640000.
20181207.
KOREA, REPUBLIC OF
샤르코-마리-투스 질환 진단용 키트(Kit for Diagnosing Charcot-Marie-Tooth).
10-1929-1630000.
20181207.
KOREA, REPUBLIC OF
샤르코-마리-투스 질환 진단용 키트(Kit for Diagnosing Charcot-Marie-Tooth).
10-1921-0270000.
20181115.
KOREA, REPUBLIC OF
ADSSL1 유전자 결핍 돌연변이 제브라피쉬 및 이의 용도.
10-2016-0006544.
20181107.
KOREA, REPUBLIC OF
샤르코 마리 투스병 치료용 약학 조성물(Pharmaceutical Composition for treating Charcot Marie Tooth disease).
10-1872105-0000.
20181106.
UNITED STATES
샤르코-마리-투스 질환 진단용 키트{Kit for Diagnosing Charcot-Marie-
Tooth}.
10-2015-0167973.
20180831.
KOREA, REPUBLIC OF
샤르코 마리 투스병 치료용 약학 조성물(Pharmaceutical Composition for treating Charcot Marie Tooth disease).
10-1872-1050000.
20180621.
KOREA, REPUBLIC OF
시신경위축 또는 감각운동신경병증의 원인 유전자로서 OPA1 및 이를 이용한 상기 질병의 진단 방법.
10-2016-0143418.
20180604.
KOREA, REPUBLIC OF
원위 근육병의 진단용 바이오 마커 및 이의 용도{Biomarkers for Diagnosing
Distal Myopathy and Uses Thereof}.
10-2015-0169203.
20180525.
KOREA, REPUBLIC OF
샤르코-마리-투스병 제2형의 원인 유전자로서 MORC2 및 이를 이용한 상기 질병의 진단방법.
10-2016-0143417.
20180411.
KOREA, REPUBLIC OF
HSP27변이(S135F)매개의 샤르코-마리-투스 질환 동물 모델.
14/873,119.
20171212.
UNITED STATES
편도 유래 중간엽 줄기세포로부터 근육 세포의 분화방법.
10-1717402.
20170310.
KOREA, REPUBLIC OF
편도 유래 중간엽 줄기세포로부터 슈반 세포의 분화 방법 {A METHOD FOR
DIFFERENTIATION OF TONSIL-DERIVED MESENCHYMAL STEM CELL INTO SCHWANN CELLS}.
10-2015-0003572.
20161207.
KOREA, REPUBLIC OF
ＨＳＰ２７ 변이(Ｓ１３５Ｆ) 매개의 샤르코-마리-투스 질환 동물모델(Animal model for HSP27 mutation(S135F)-mediated Charcot-Marie-Tooth disease).
PCT/KR2014/002795.
20160421.
KOREA, REPUBLIC OF
Conference Paper
(2031)
The Clinical and Electrophysiological Findings in Korean Patients with Charcot-Marie-Tooth X 1.
2013 대한퇴행성신경질환학회 추계학술대회.
KOREA, REPUBLIC OF
(2020)
Different neuroimaging findings in a cohort of CMT patients with GDAP1 mutations.
대한퇴행성신경질환학회.
KOREA, REPUBLIC OF
(2020)
Identification of the therapeutic potency and selectivity of a novel HDAC6 inhibitor for CMT1A in a mouse model.
대한퇴행성신경질환학회.
KOREA, REPUBLIC OF
(2020)
Phenotypic characteristics of Int-CMT patients with AARS1 gene mutation.
대한퇴행성신경질환학회.
KOREA, REPUBLIC OF
(2020)
A novel HDAC6 inhibitor ameliorates the clinical phenotype in a mouse model of Charcot-Marie-Tooth disease type 1A.
대한신경근육질환학회.
KOREA, REPUBLIC OF
(2020)
Gait improvement by inhibition of Myostatin in a mouse model of Charcot-Marie-Tooth type 1A.
대한신경근육질환학회.
KOREA, REPUBLIC OF
(2020)
A novel HDAC6 inhibitor ameliorates the clinical phenotype in a mouse model of Charcot-Marie-Tooth disease type 1A.
대한신경과추계학술대회.
KOREA, REPUBLIC OF
(2020)
Clinical and neuroimaging findings in a cohort of Korean Charcot-Marie-Tooth patients with GDAP1 mutations.
대한신경과추계학술대회.
KOREA, REPUBLIC OF
(2020)
Gait improvement by inhibition of Myostatin in a mouse model of Charcot-Marie-Tooth type 1A.
대한신경과추계학술대회.
KOREA, REPUBLIC OF
(2020)
Intermediate Charcot-Marie-Tooth patients with Alanyl-tRNA synthetase 1 (AARS1) gene mutation.
대한신경과추계학술대회.
KOREA, REPUBLIC OF
(2020)
Specific characteristics in Korean patients with de novo PMP22 duplications.
대한신경과추계학술대회.
KOREA, REPUBLIC OF
(2020)
Inhibition of Myostatin as a Potential Treatment for Demyelinating Peripheral Neuropathy.
ICGSK 2020.
KOREA, REPUBLIC OF
(2020)
Phenotypic Characterization of Charcot-Marie-Tooth Disease Patients with GDAP1 Mutations.
ICGSK 2020.
KOREA, REPUBLIC OF
(2020)
Clinical and neuroimaging findings of patients with Charcot-Marie-Tooth disease harboring AARS1 gene mutations.
KSBNS 2020.
KOREA, REPUBLIC OF
(2020)
Clinical characterization in de novo Charcot-Marie-Tooth 1A patients with 17p12 duplication.
KSBNS 2020.
KOREA, REPUBLIC OF
(2020)
Evaluation of the therapeutic potential of a novel HDAC6 inhibitor in a mouse model of Charcot-Marie-Tooth disease type 1A.
KSBNS 2020.
KOREA, REPUBLIC OF
(2019)
A novel mutation of PHKA1 in Korean family with X-linked glycogen storage disease type IXD.
한국통합생물학회.
KOREA, REPUBLIC OF
(2019)
A proof-of-concept of CMT1A therapy with CRISPR/Cas9 using Schwann cell differentiation of patient-derived iPSCs and mouse model.
한국통합생물학회.
KOREA, REPUBLIC OF
(2019)
Establishment of motor and sensory nerve conduction study methods on wild type and CMT1A model mouse.
한국통합생물학회.
KOREA, REPUBLIC OF
(2019)
phenotypic characterization of autosmal recessive Charcot-Marie-Tooth disease type 4C with SH3TC2 mutations.
한국통합생물학회.
KOREA, REPUBLIC OF
